Vutiglabridin Clinical Trials

2 actively recruiting trials

Also known as: 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, HSG4112, HSG4112,2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol

Filter by location:

Other2 trials

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Phase 2

A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.